Piramal Pharma Limited discloses a legal dispute
In short
Piramal Pharma Limited made a disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. No figures, breakdowns, dates, or scheme deadlines are given in the text. In simple terms, the company is notifying the market under a stock-exchange disclosure rule, but the excerpt provided does not say what changed or what it affects. No closing or validity period is stated.
Why it matters
A legal dispute has been disclosed — the filing's own description of the claim amount and status is the primary fact here. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.